The infectious disease diagnosis market has been confirmed to make even greater progress in the future. Today’s futuristic cutting-edge technologies such as IoT, AI, and big data work better with ultra-fast and reliable Internet connections. The benefits of high-speed Internet will be seen in telecare in the next few years, but in the future, more authentic data streams can create better connected devices, thereby revolutionizing the healthcare system. There is sex.
According to the latest market report published by Persistence Market Research, entitled “World Market Research on Infectious Disease Diagnosis: Increasing Demand for Evidence-Based Treatment to Increase Demand for Infectious Disease Diagnostic Tests During Prediction Period” .. The global market for infectious disease diagnostics is estimated to reach US $ 876.6 million in 2016 from US $ 827.7 million in 2015 due to increased demand for diagnostic kits due to increased incidence of infectious diseases. ..
Get a sample copy of this report @ https : //www.persistencemarketresearch.com/samples/11413
The global infectious disease diagnostics market is expected to reach US $ 150.38 million by 2024 . The Sexually Transmitted Diseases (STD) segment is expected to continue to be the largest segment due to the signs of the disease, which accounted for US $ 282.4 million in sales in 2016 . Y – o – Y will increase by 7.0% compared to 2015. The Chlamydia Diagnostic Test Kit is expected to gain momentum in 2016, with sales up 8.9%, the fastest in the disease indication segment.
Company Profile:
- Becton Dickinson & Company
- Cepheid, Inc.
- Abbott Laboratories
- bioMerieux SA
- Hologic, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Co., Ltd.
- Roche Diagnostics
- Allera Co., Ltd.
- DiaSorin SpA
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- other
Methodology Request @ https : //www.persistencemarketresearch.com/methodology/11413
The cell culture segment is expected to record the highest CAGR of revenue by test type, which will account for US $ 311.4 million in revenue in 2016. The affordability of cell culture kits and large-scale applications in the diagnosis of several infectious diseases are attracting attention. Demand for cell culture test kits will witness a 7.2% growth rate in 2016 compared to 2015.
The diagnostic center end-user segment is expected to record the highest CAGR of revenue, accounting for US $ 392.8 million in revenue in 2016. The number of diagnostic centers is increasing around the world, and the patient pool is increasing depending on the diagnostic center. The increase in infectious diseases is expected to increase the demand for diagnostic tests between diagnostic centers. The diagnostic center end-user segment witnesses a 7.4% growth rate in 2016 compared to 2015.
PMR’s long-term outlook : PMR predicts that the global infectious disease diagnostics market will grow moderately during the 2016-2024 forecast period. The Asia Pacific region remains the largest market for infectious disease diagnosis, recording a CAGR of 7.9% over the predicted period .
Access the full report @ https: //www.persistencemarketresearch.com/checkout/11413
About us: Persistence market research
inquiry:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
US Ph. – + 1-646-568-7751
USA-Canada Toll Free – +1 800-961-0353
Sales – sales @ persistencemarketresearch .com
